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Temporomandibular dysfunction is characterized by the presence of painful joint/muscular 
symptoms muscle in the face. The main justification for the use of lasers in laser therapy dysfunction 
is its analgesic effect, which was observed in most studies in the literature. 
Aim: We evaluated the effectiveness of laser therapy in the treatment of temporomandibular disorders. 
Methods: 50 volunteers with temporomandibular disorders were divided into two groups (control 
and experimental) had amplitudes of movements of mouth opening, right and left laterality recorded 
before and after laser application. Was also recorded, the score the individual gave to pain by 
visual analog scale and, through physical examination, the pain points. We used the AsGaAl laser 
with a 40mW power, with 80J/cm² for 16 seconds at four selected points for just one session with 
reassessment after a week. Study design: Clinical. 
Results: It was noted that laser therapy increased the mean amplitude of mandibular movements (p 
= 0.0317) and decreased significantly (43.6%) the pain intensity measured by the visual analog scale. 
Conclusions: The laser decreases the painful symptoms of the patient after application through its 
analgesic and/or a placebo effect.
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INTRODUCTION
Temporomandibular joint dysfunction (TMJD) or 
temporomandibular disorder (TMD) is characterized by 
facial muscle/joint pain, especially in the acute phase1-5. 
TMD has numerous signs and symptoms: muscle and/or 
joint pain, joint noises, earache, mandible shifting and, in 
the most severe cases, dislocations2-3.
The main justification as to the use of low intensity 
laser (laser therapy) on TMD is its analgesic effect reported 
by most of the studies found in the literature6-16.
According to Medeiros13, many studies show that 
laser increases the amount of collagen in the wound, 
causing angiogenesis and reducing lesion repair time, 
increasing the number of cells available for healing. Ac-
cording to Freitas et al.14, often times laser therapy can 
be used in lieu of anti-inflammatory medication, thus, 
preventing side effects. Nonetheless, Beckerman et al.7 
reported effects arising from laser therapy - transitional 
pins and needles, mild erythema, a burning feeling, pain 
increase and exanthema.
The low intensity laser is, in many cases, a new 
treatment mode for the treatment of maxillofacial region 
disorders such as joint pain, neuralgias and paresthesias7.
Despite the numerous treatment modes available 
for TMD, only low intensity laser has proven capable of 
relieving pain in minutes after administration, bringing 
about a significant improvement to the patient. Despite all 
these benefits brought about by laser treatment, it is not the 
definitive treatment for TMD. It works as a coadjuvant in 
the treatment alleviating pain thanks to the laser’s analgesic 
effect, which allows the patient to promptly resume her/
his functions, providing greater comfort6. Nonetheless, for 
a safe use of laser with patients, the professionals must be 
trained to use the equipment, thus reducing the possibility 
of iatrogenic effects.
The goal of the present study was to assess the 
efficacy of laser treatment in the management of TMD 
by means of the Visual Analogue Pain Scale (VAPS) and 
measuring the range of mandibular movements.
MATERIALS AND METHODS
This study was made up of a descriptive survey of 
the clinical picture and results obtained after the exam and 
administration of laser treatment, with later reassessment 
of the laser use, in TMD patients feeling pain. We had 
50 volunteers who agreed to sign the Free and Informed 
Consent Form (FICF). This study followed the requirements 
established on Resolution # 196/96 from the National He-
alth Board/Ministry of Health - Brazil, and was approved 
by the Ethics in Research Committee of our Institution, 
under protocol # 137/2004.
The patients were broken down in two groups of 25 
patients each - study and control groups. According to the 
methodology advocated by Kulekcioglu et al.15 - and with 
some changes done exclusively for this study we employed 
the VAPS so that later we would select four laser applica-
tion points. These four points would be those which had 
the highest sensitivity/pain score among 17 assessed sites: 
joint capsule (lateral, posterior and superior); masseter 
(anterior, inferior); temporal (anterior, middle, posterior, 
origin and insertion); medial and lateral pterygoid, ster-
nocleidomastoid (superior, inferior and middle); trapezius 
muscle (origin and superior).
After filling out the guided questionnaire and un-
dergoing physical exam, we assessed the individual’s pain 
intensity through the EVAD before using the laser and after 
one of week of use (reassessment) according to what was 
done in other studies6,10,11,14,15,17,18.
We used the Ultrablue dental laser (D.M.C. Equip-
ment®), with a maximum power of 120 J/cm², diode laser 
power of 800 mW, with beam divergence of 8°x28°, with 
irradiation area of 5mm² without the application tip and 
an area of 4 mm² with the administration tip, there was a 
20% power loss with the 830 nm wavelength (visible in 
red) and AsGaAl diode laser semiconductor, it was punc-
tually deployed on the TMJ and smaller muscles, based 
on shooting the laser on strategic points over the affected 
area and using the scanning technique, in which the laser 
is moved up and down throughout the entire affected 
area. In the control group the device was off during the 
application. In order to make sure the patient would not 
perceive it, he/she was asked to close the eyes, besides 
wearing goggles - as a means of eye protection. The laser 
therapy efficacy was also assessed through measuring 
the range of motion of the maximum mouth opening the 
patient could get, as well as left and right laterality.
We carried out a descriptive analysis with a quanti-
tative approach of the Visual Analogue Scale (VAS) values, 
mouth opening amplitude, lateral movements and main 
places which were most affected by sensitivity/pain. We 
used the Epi Info 3.2 software, through which we did 
the ANOVA statistical tests (variance analysis) -in order 
to assess pain intensity; and that of Wilcoxon -in order to 
assess the range of mandible motion.
RESULTS
From the study group we obtained an initial average 
value of the pain score, through the Visual Analogue Pain 
Scale, of 5.14. After the reassessment we had the mean 
score of 2.9. According to the ANOVA test, the result was 
statistically significant (p=0.0317), which was different 
from that of the control group, which initial mean value 
was 5.4 and after reassessment it was 4.25 - a statistically 
significant result (p=0.2371).
According to Table 1, only one patient of the group 
presented an increase in pain intensity during reassess-
ment.
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Of the studied patients, 92.0% had pain in one or 
more points on the Masseter muscle (origin, body and 
insertion) and/or in two on the TMJ (pre-auricular and 
intrameatal) (Table 2).
In the study group 72.0% of the patient had a 
mandibular cracking sound upon initial visit and, after 
undergoing laser therapy, it dropped to 33.0%. Therefore, 
there was a 54.1% reduction in the cases of patients with 
the cracking sounds (Graph 1).
The mean value of the initial mouth opening range 
of motion of the volunteers in our study was 41mm, while 
the final, measured one week after using the laser was 
42.28mm, which represented an improvement of 1.28mm 
(3.12%). According to the Wilcoxon test it was statistically 
significant (p= 0.0409). The initial and final right side late-
rality were: 7.44mm and 7.6mm respectively, while those 
for the left wide were: 7.12mm and 7.88mm (Table 3).
DISCUSSION
Despite the recent growing use of laser therapy, its 
action on the tissues is still inaccurate. It is known that, 
according to wavelength, the laser light has the capacity 
to alter cell functions (production of beta-endorphins, 
increase in protein synthesis, excretion, metabolism, cell 
division and repair) and, depending on the dose, it can 
inhibit or stimulate some of these functions11-12.
Despite the lack of scientific evidence regarding its 
mechanism of action10-11, some theories try to explain its 
therapeutic effects: greater release of beta-endorphins11; 
maintaining the nerve cell membrane potential - reducing 
the transmission of nerve signals19 and COX inhibition, 
reducing local pro-inflammatory substances20, and these 
all yield analgesic and anti-inflammatory effects.
Lopez21 stressed that, although laser therapy can 
reduce the pain in the individuals studied, in cases of 
muscle pain it returned shortly after to its initial values; 
nonetheless, in cases of joint pain, there was a marked 
reduction. Gray et al.8 described the laser as being efficient 
to control pain; however, they did not define it as the best 
treatment choice when compared to occlusal plaques, 
considered the best treatment option by the authors.
Placebo studies are paramount as long as ethics are 
respected. Refraining from using placebo can lead to the 
indication of inefficient treatment - to be considered as 
unethical behavior. Studies have shown that placebo, in 
Table 1. VAPS Score at the initial moment and after reassessment
Gr 
Study 
Group
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Initial 7,5 3,5 6 3,5 5 6 7,5 2,5 8 6 2 5 8 3 5 7 5 3,5 5 3 4 7 3 10 2,5
Final 3 3,5 3 2,5 3,5 3 5 2 3 8 2 0 5 1 0 3 3 3 3 2 2 5 2 4 1
 p-Value 0.0317*
G G 
Control 
Group
26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50
Initial 6 4,5 8 3 10 5 7 7 3 6 5 3 8 6 4 3,5 9 2 4 5 3 7 4 10 2
Final 5 4 9 1 10 5 9 6 0 5,5 3 5 6 5 4 3 7 2 1 4 2,5 5 5 9 0
p-Value 0,2371*
* ANOVA Test
Table 2. Pain sites during mandibular movement in the patients of 
the study group
Site %
TMJ 73,7%
Temporal 10,5%
Masseter 15,8%
Total 76,0%
Graph 1. Joint noises present before and after the administration of 
laser therapy in the study group.
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fact, causes a biological response, as well as a behavioral 
one in a broad variety of medical conditions22. The place-
bo laser has been used in clinical research in an attempt 
to understand the true benefit of the therapeutic laser, 
although the results are still controversial23,24.
In the present study, there was a 43.6% reduction in 
pain in the individuals of the study group, in the control 
group, the reduction was only of 21.3%. However, since 
there was only one laser application, this result can be 
largely attributed to the positive psychological effect of 
the laser treatment in accordance with the studies from 
Pinheiro et al.11,12 after all, the control group also suffered 
a reduction, although of a lesser effect. Nonetheless, the 
different results between the study group and the control 
group reinforce the therapeutic value of the laser therapy, 
although it is not possible to rule out the possibility of 
its strengthening by the psychological effect, as well as 
the spontaneous regression of some acute flare up. Other 
studies did not report on the analgesic effect of the low 
power laser in the orofacial pain, being different from the 
results attained17,23,25. Although Hansen and Thoroe17 and 
Conti10 found pain reduction through the VAPS, they did 
not find significant differences between the study group 
and the placebo group.
The 54.16% reduction in the cases of patients with 
cracking sounds is corroborated by the study of Lopez21, 
in which one of the findings after laser therapy was a 
reduction in joint noises. On the other hand, it disagreed 
from the findings by Kulekcioglu et al.15, since they did not 
find the laser effects on the sounds present in the study 
groups (Graph 1).
Table 3. Values in millimeters of the mandible movements from the individuals in the experimental group.
Individuals Mouth opening Right side laterality Left side laterality
 Initial Final Initial Final Initial Final
1 42 42 8 8 4 6
2 50 50 10 10 10 10
3 43 42 7 10 8 7
4 30 38 12 12 10 9
5 28 30 6 7 5 5
6 52 52 10 10 7 10
7 44 45 7 8 6 6
8 40 37 4 5 4 7
9 44 45 7 10 7 10
10 48 50 6 9 5 6
11 33 33 5 5 7 6
12 41 42 5 6 7 7
13 41 43 3 4 5 6
14 33 33 6 6 8 8
15 45 42 10 8 12 12
16 38 40 6 6 5 6
17 43 42 8 7 10 10
18 42 41 8 8 9 8
19 40 40 8 8 3 4
20 50 45 8 10 5 10
21 52 53 9 10 8 8
22 45 45 5 5 12 11
23 41 42 7 8 7 8
24 19 23 8 10 7 9
25 41 42 7 7 7 8
Mean 41,0 42,2 7,4 7,6 7,1 7,8
p-Value 0,0409*  
* Wilcoxon Test
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The results from this study, as well as those from 
other studies showed that there was a greater mean man-
dible range of motion after laser administration9,10,15,18, 
indicating that laser therapy was a means of treatment 
which caused satisfactory effects on the parameters used. 
The small variation can be associated to the quantity ad-
ministered, although Pizzo et al.26 and Fikackova et al.27 
found similar results from the placebo group.
CONCLUSIONS
TMJ and the masseter muscle are the sites most 
affected by pain in patients with TMJD. The masseter 
and sternocleidomastoid muscles are frequently the most 
painful in those with joint noise. Laser therapy caused a 
reduction in the pain symptom after administration, by 
its analgesic action or a placebo effect resulting from an 
increase in the mean value of mandible movements. We 
found similar results in the control group, representing 
the positive psychological effect of laser therapy in these 
patients. 
REFERENCES
 1. Pullinger AG, Seligman DA, Gornbein JA. A multiple logistic regres-
sion analysis of the risk and relative odds of têmporo-mandibular 
disorders as a function of common occlusal features. J Dent Res. 
1993;72(6):968-79.
 2. McNeill C. History and evolution of TMD concepts. Oral Surg Oral 
Med Oral Pathol Oral Radiol Endod. 1997;83(1):51-60.
 3. Hotta TH, Nunes LJ, Quatrini AH, Bataglion C, Nonaka T, Bezzon OL. 
Tooth wear and loss: Symptomatological and rehabiliting treatments. 
Braz Dent J. 2000;11(2):147-52.
Table 4. Values in millimeters of the mandible movements from the individuals in the control group.
Individuals Mouth opening Right side laterality Left side laterality
 Initial Final Initial Final Initial Final
1 35 35 10 10 8 7
2 45 47 7 7 7 8
3 43 41 8 9 6 7
4 32 35 10 9 10 10
5 41 40 6 7 5 5
6 46 48 8 8 9 7
7 36 38 10 11 10 10
8 26 28 6 5 5 6
9 42 42 3 5 6 6
10 43 43 4 4 6 7
11 49 48 10 10 8 9
12 39 42 5 6 6 5
13 41 42 5 7 4 7
14 41 41 3 4 5 7
15 41 42 8 10 10 9
16 37 39 10 11 11 10
17 23 26 7 8 8 8
18 35 38 7 9 9 8
19 43 40 9 6 7 6
20 40 42 7 6 6 8
21 40 41 5 7 7 9
22 44 45 8 7 9 8
23 26 27 6 8 8 7
24 32 35 8 9 8 6
25 41 42 7 7 6 4
Mean 38,4 39,4 7,0 7,6 7,3 7,3
p-value 0,0972*  
* Wilcoxon test
299
Brazilian Journal of otorhinolaryngology 76 (3) May/June 2010
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
 4. Karibe H, Goddard G, Gear RW. Sex differences in masticatory muscle 
pain after chewing. J Dent Res. 2003;82(2):112-6.
 5. Yap AU, Chua EK, Tan KB. Depressive symptoms in Asian TMD 
patients and their association with non-specific physical symptoms 
reporting. J Oral Pathol Med. 2004;33(5):305-10.
 6. Hansson TL. Infrared laser in the treatment of craniomandibular 
disorders arthrogenous pain. J Prosth Dent. 1989;61(5):614-17.
 7. Beckerman H, Bie RA, Bouter LM, Cuyper HJ, Oostendorp RA. The 
efficacy of laser therapy for musculoskeletal and skin disorders: a 
criteria-based meta-analysis of randomized clinical trials. Phys Ther. 
1992;72(7):483-91.
 8. Gray RJ, Quayle AA, Hall CA, Schofield MA. Physiotherapy in the 
treatment of têmporo-mandibular joint disorders: A comparative study 
of four treatment methods. Br Dent J. 1994;176(7):257-61.
 9. Rodrígez Dorta PM, González González J. Laser terapia en artritis 
têmporo-mandibulares - Evaluacion gammagrafica. Acta Odontológica 
Venezolana. 1995;33(2):21-3.
10. Conti PC. Low level laser therapy in the treatment of têmporo-
mandibular disorders (TMD): a double blind pilot study. Cranio. 
1997;15(2):144-9.
11. Pinheiro ALB, Cavalcanti ET, Rego T, Pinheiro M, Manzi CTA. Low-
level laser therapy in the management of disorders of the maxillofacial 
region. J Clin Laser Med Surg. 1997;15(4):181-3.
12. Pinheiro ALB, Cavalcanti ET, Pinheiro TITNR, Alves MJPC, Miranda 
ER, Quevedo A, Manzi CTA, Vieira ALB, Rolim AB. Low-level laser 
therapy is an important tool to treat disorders of the maxillofacial 
region. J Clin Laser Med Surg. 1998;16(4):223-6.
13. Medeiros JS. O efeito da aplicação do laser no músculo masseter so-
bre a força de mordida, como auxílio na terapêutica da dor orofacial 
[dissertação]. São Paulo (SP): Universidade de São Paulo; 2000.
14. Freitas AC, Pinheiro ALB, Miranda P, Thiers FA, Vieira ALB. Assess-
ment of anti-inflammatory effect of 830nm laser light using C-reactive 
protein levels. Braz Dent J. 2001;12(3):187-90.
15. Kulekcioglu S, Sivrioglu K, Ozcan O, Parlak M. Effectiveness of 
low-level laser therapy in têmporo-mandibular disorder. Scand J 
Rheumatol. 2003;32(2):114-8.
16. Kreisler MB, Haj HA, Noroozi N, Willershausen B. Efficacy of low 
level laser therapy in reducing postoperative pain after endodontic 
surgery - A randomized double blind clinical study. Int J Oral Ma-
xillofac Surg. 2004;33(1):38-41.
17. Hansen HJ, Thoroe U. Low power laser biostimulation of chronic 
orofacial pain. A double-blind placebo controlled cross-over study 
in 40 patients. Pain. 1990;43(2):169-79.
18. Bertolucci LE, Grey T. Clinical comparative study of microcurrent elec-
trical stimulation to mid-laser and placebo treatment in degenerative 
joint disease of the têmporo-mandibular joint. Cranio. 1995;13(2):116-
20.
19. Sandoval RL, Koga DH, Buloto LS, Suzuki R, Dib LL. Management 
of chemo- and radiotherapy induced oral mucositis with low-energy 
laser: Initial Results of A.C. Camargo Hospital. J Appl Oral Sci. 
2003;11(4):337-41.
20. Almeida MG, Pagnoncelli RM. O uso do laser de baixa potência no 
tratamento das disfunções têmporo-mandibulares: Uma revisão. JBA. 
2004;3(13):15-9.
21. Lopez VJ. El laser en el tratamiento de las disfunciones de ATM. Rev 
Actual Estomatol Madrid. 1986;46(355):35-40.
22. Greene CS, Goddard G, Macaluso GM, Mauro G. Topical review: 
placebo responses and therapeutic responses. How are they related? 
J Orofac Pain. 2009;23(2):93-107.
23. Emshoff R, Bosch R, Pumpel E, Schoning H, Strobl H. Low-level laser 
therapy for treatment of têmporo-mandibular joint pain: a double-
blind and placebo-controlled trial. Oral Surg Oral Med Oral Pathol 
Oral Radiol Endod. 2008;105(4):452-6.
24. Shirani AM, Gutknecht N, Taghizadeh M, Mir M. Low-level laser 
therapy and myofacial pain dysfunction syndrome: a randomized 
controlled clinical trial. Lasers Med Sci. 2009;24(5):715-20.
25. Gam AN, Thorsen H, Lonnberg F. The effect of low-level laser therapy 
on musculoskeletal pain: a meta-analysis. Pain. 1993;52(1):63-6.
26. Pizzo RCA, Mazzetto MO, Hotta TH. Avaliação do tratamento com 
laser de baixa intensidade na movimentação mandibular ativa. JBA. 
2004;4(14):39-44.
27. Fikackova H, Dostalova T, Navratil L, Klaschka J. Effectiveness of 
low-level laser therapy in têmporo-mandibular joint disorders: a 
placebo-controlled study. Photomed Laser Surg. 2007;25(4):297-303.
